Whitehawk Therapeutics, Inc. WHWK
3.74
(0.12)
(3.11%)
as of 25 Sep
- Market cap
- $220.1M
- P/E
- 0.0×
Follow WHWK
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
16.51 | 10.03 | 11.13 | 17.16 | |
Current Ratio |
16.76 | 10.26 | 11.36 | 17.38 | |
Net Debt/EBITDA |
8.03 | 5.67 | 5.16 | 10.29 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.87 | 0.74 | 1.00 | 0.87 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.22) | (0.28) | (0.32) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.22) | (0.28) | (0.32) | (0.18) | |
Cash per Share |
2.35 | 2.35 | 1.78 | 2.29 | |
Shareholders Equity per Share |
2.27 | 2.20 | 1.68 | 2.21 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.27 | 2.20 | 1.68 | 2.21 | |
Free Cash Flow |
(15.38) | (17.23) | (22.21) | (14.53) | |
Working Capital |
155.19 | 134.49 | 114.49 | 181.35 | |
Capital Expenditures |
0.00 | 0.00 | — | — | |
Net Current Asset Value |
155.19 | 134.49 | 114.49 | 181.35 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.50 | 1.54 | 2.70 | 2.22 | |
Average Assets |
126.36 | 110.57 | 180.62 | 187.41 | |
Average Common Equity |
113.02 | 94.39 | 168.95 | 177.50 |
Columns are period end dates